Search
for
Sort by
Research 151–180 of 580
- Role and Mechanisms of Phytochemicals in Hair Growth and Health
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Optimization of photobiomodulation therapy for spinal cord injury: A review
- The Extract of Periplaneta americana (L.) Promotes Hair Regrowth in Mice with Alopecia by Regulating the FOXO/PI3K/AKT Signaling Pathway and Skin Microbiota
- Exploring lncRNA-Mediated Mechanisms in Muscle Regulation and Their Implications for Duchenne Muscular Dystrophy
- Table_1_Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea.xlsx
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Ruxolitinib found to cause eyelash growth: a case report
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Alopecia areata – Current understanding and management
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Pathologic Quiz Case: A Nodule on the Back
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Cold Atmospheric Plasma for Breast Cancer
- Treatments for alopecia areata: a network meta-analysis
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy